Heart and Vascular
ATR 1072-CS1
Heart Failure
A Phase 1/2, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous ATR 1072 for the Treatment of PRKAG2 Syndrome
Contact Research Team:
[email protected]
Site principal investigator:
Michael Nassif, MD
Learn more about this study:
NCT07738107